Atlas Trials

Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases

Clinical trial NCT06777433 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06777433
Sponsor
Radiopharm Theranostics, Ltd
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Brain Metastases From Solid Tumors
Start date
2024-12-13
Primary completion
2026-04-23
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.